RNA 추출 및 정제 시장 규모, 점유율 및 동향 분석 보고서 : 제품별, 용도별, 방법별, 최종 용도별, 지역별 및 부문별 예측(2026-2033년)

RNA Extraction And Purification Market Summary

The global RNA extraction and purification market size was estimated at USD 2.51 billion in 2025 and is projected to reach USD 5.10 billion by 2033, growing at a CAGR of 9.4% from 2026 to 2033. This growth is primarily driven by the increasing demand for RNA-based therapeutics and vaccines, expanding applications in genomics and transcriptomics research, and the rising adoption of molecular diagnostics and infectious disease testing.

Global RNA Extraction And Purification Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global RNA extraction and purification market based on product, application, method, end use, and region.

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Kits & Reagents
• Instruments
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Precision Medicine
• Diagnostics
• Drug Discovery & Development
• Agriculture and Animal Research
• Other Applications
• Method Outlook (Revenue, USD Million, 2021 - 2033)
• Column based
• Magnetic Beads
• Reagent based
• Others
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Academic Research Institutes
• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations
• Hospitals and Diagnostic Centers
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
  • 1.2.1. Product
  • 1.2.2. Application
  • 1.2.3. Method
  • 1.2.4. End Use
• 1.3. Information analysis
• 1.4. Market formulation & data visualization
• 1.5. Data validation & publishing
• 1.6. Information Procurement
  • 1.6.1. Primary Research
• 1.7. Information or Data Analysis
• 1.8. Market Formulation & Validation
• 1.9. Market Model
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Ancillary Market Outlook
• 3.2. Market Trends and Outlook
• 3.3. Market Dynamics
  • 3.3.1. Market Driver Impact Analysis
    • 3.3.1.1. Increasing Demand for RNA-Based Therapeutics and Vaccines
    • 3.3.1.2. Growing Expansion of Genomics, Transcriptomics, and Life Science Research
    • 3.3.1.3. Rising Adoption of Molecular Diagnostics and Infectious Disease Testing
  • 3.3.2. Market Restraint Impact Analysis
    • 3.3.2.1. High cost of instruments and reagents
    • 3.3.2.2. Complex Regulatory and Quality Compliance
  • 3.3.3. Market Challenges Analysis
  • 3.3.4. Market Opportunity Analysis
• 3.4. Case Study Insights
• 3.5. Business Environment Analysis
  • 3.5.1. PESTLE Analysis
  • 3.5.2. PORTER'S Five Forces Analysis

Chapter 4. Product Business Analysis

• 4.1. Product Segment Dashboard
• 4.2. Global RNA Extraction and Purification Market Product, Movement Analysis
• 4.3. Global RNA Extraction and Purification Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
• 4.4. Kits & Reagents
  • 4.4.1. Global kits & reagents market estimates and forecasts, 2021 - 2033 (USD Million)
• 4.5. Instruments
  • 4.5.1. Global instruments market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Application Business Analysis

• 5.1. Application Segment Dashboard
• 5.2. Global RNA Extraction and Purification Market Application, Movement Analysis
• 5.3. Global RNA Extraction and Purification Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 5.4. Precision Medicine
  • 5.4.1. Global precision medicine market estimates and forecasts, 2021 - 2033 (USD Million)
• 5.5. Diagnostics
  • 5.5.1. Global diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
• 5.6. Drug Discovery and Development
  • 5.6.1. Global drug discovery and development market estimates and forecasts, 2021 - 2033 (USD Million)
• 5.7. Agriculture and Animal Research
  • 5.7.1. Global agriculture and animal research market estimates and forecasts, 2021 - 2033 (USD Million)
• 5.8. Other Applications
  • 5.8.1. Global other applications market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. Method Business Analysis

• 6.1. Method Segment Dashboard
• 6.2. Global RNA Extraction and Purification Market Method, Movement Analysis
• 6.3. Global RNA Extraction and Purification Market Size & Trend Analysis, by Method, 2021 to 2033 (USD Million)
• 6.4. Column based
  • 6.4.1. Global column based market estimates and forecasts, 2021 - 2033 (USD Million)
• 6.5. Magnetic Beads
  • 6.5.1. Global magnetic beads market estimates and forecasts, 2021 - 2033 (USD Million)
• 6.6. Reagent based
  • 6.6.1. Global reagent based market estimates and forecasts, 2021 - 2033 (USD Million)
• 6.7. Others
  • 6.7.1. Global others market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. End Use Business Analysis

• 7.1. End Use Segment Dashboard
• 7.2. Global RNA Extraction and Purification Market End Use, Movement Analysis
• 7.3. Global RNA Extraction and Purification Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 7.4. Academic and Research Institutes
  • 7.4.1. Global academic and research institutes market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.5. Pharmaceutical & Biotechnology Companies
  • 7.5.1. Global pharmaceutical & biotechnology companies market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.6. Contract Research Organizations
  • 7.6.1. Global contract research organizations market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.7. Hospitals and Diagnostic Centers
  • 7.7.1. Global hospitals and diagnostic centers market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.8. Others
  • 7.8.1. Global others market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. RNA Extraction and Purification: Regional Estimates and Trend Analysis, by Product, Application, Method & End Use

• 8.1. Regional Dashboard
• 8.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
• 8.3. North America
  • 8.3.1. North America RNA extraction and purification market, 2021 - 2033 (USD Million)
  • 8.3.2. U.S.
    • 8.3.2.1. Key Country Dynamics
    • 8.3.2.2. Competitive Scenario
    • 8.3.2.3. Regulatory Framework
    • 8.3.2.4. U.S. RNA extraction and purification market, 2021 - 2033 (USD Million)
  • 8.3.3. Canada
    • 8.3.3.1. Key Country Dynamics
    • 8.3.3.2. Competitive Scenario
    • 8.3.3.3. Regulatory Framework
    • 8.3.3.4. Canada RNA extraction and purification market, 2021 - 2033 (USD Million)
  • 8.3.4. Mexico
    • 8.3.4.1. Key Country Dynamics
    • 8.3.4.2. Competitive Scenario
    • 8.3.4.3. Regulatory Framework
    • 8.3.4.4. Mexico RNA extraction and purification market, 2021 - 2033 (USD Million)
• 8.4. Europe
  • 8.4.1. Europe RNA extraction and purification market, 2021 - 2033 (USD Million)
  • 8.4.2. UK
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. Competitive Scenario
    • 8.4.2.3. Regulatory Framework
    • 8.4.2.4. UK RNA extraction and purification market, 2021 - 2033 (USD Million)
  • 8.4.3. Germany
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Competitive Scenario
    • 8.4.3.3. Regulatory Framework
    • 8.4.3.4. Germany RNA extraction and purification market, 2021 - 2033 (USD Million)
  • 8.4.4. France
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. Competitive Scenario
    • 8.4.4.3. Regulatory Framework
    • 8.4.4.4. France RNA extraction and purification market, 2021 - 2033 (USD Million)
  • 8.4.5. Italy
    • 8.4.5.1. Key Country Dynamics
    • 8.4.5.2. Competitive Scenario
    • 8.4.5.3. Regulatory Framework
    • 8.4.5.4. Italy RNA extraction and purification market, 2021 - 2033 (USD Million)
  • 8.4.6. Spain
    • 8.4.6.1. Key Country Dynamics
    • 8.4.6.2. Competitive Scenario
    • 8.4.6.3. Regulatory Framework
    • 8.4.6.4. Spain RNA extraction and purification market, 2021 - 2033 (USD Million)
  • 8.4.7. Denmark
    • 8.4.7.1. Key Country Dynamics
    • 8.4.7.2. Competitive Scenario
    • 8.4.7.3. Regulatory Framework
    • 8.4.7.4. Denmark RNA extraction and purification market, 2021 - 2033 (USD Million)
  • 8.4.8. Sweden
    • 8.4.8.1. Key Country Dynamics
    • 8.4.8.2. Competitive Scenario
    • 8.4.8.3. Regulatory Framework
    • 8.4.8.4. Sweden RNA extraction and purification market, 2021 - 2033 (USD Million)
  • 8.4.9. Norway
    • 8.4.9.1. Key Country Dynamics
    • 8.4.9.2. Competitive Scenario
    • 8.4.9.3. Regulatory Framework
    • 8.4.9.4. Norway RNA extraction and purification market, 2021 - 2033 (USD Million)
• 8.5. Asia Pacific
  • 8.5.1. Asia Pacific RNA extraction and purification market, 2021 - 2033 (USD Million)
  • 8.5.2. Japan
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Competitive Scenario
    • 8.5.2.3. Regulatory Framework
    • 8.5.2.4. Japan RNA extraction and purification market, 2021 - 2033 (USD Million)
  • 8.5.3. China
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Competitive Scenario
    • 8.5.3.3. Regulatory Framework
    • 8.5.3.4. China RNA extraction and purification market, 2021 - 2033 (USD Million)
  • 8.5.4. India
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Competitive Scenario
    • 8.5.4.3. Regulatory Framework
    • 8.5.4.4. India RNA extraction and purification market, 2021 - 2033 (USD Million)
  • 8.5.5. Australia
    • 8.5.5.1. Key Country Dynamics
    • 8.5.5.2. Competitive Scenario
    • 8.5.5.3. Regulatory Framework
    • 8.5.5.4. Australia RNA extraction and purification market, 2021 - 2033 (USD Million)
  • 8.5.6. Thailand
    • 8.5.6.1. Key Country Dynamics
    • 8.5.6.2. Competitive Scenario
    • 8.5.6.3. Regulatory Framework
    • 8.5.6.4. Thailand RNA extraction and purification market, 2021 - 2033 (USD Million)
  • 8.5.7. South Korea
    • 8.5.7.1. Key Country Dynamics
    • 8.5.7.2. Competitive Scenario
    • 8.5.7.3. Regulatory Framework
    • 8.5.7.4. South Korea RNA extraction and purification market, 2021 - 2033 (USD Million)
• 8.6. Latin America
  • 8.6.1. Latin America RNA extraction and purification market, 2021 - 2033 (USD Million)
  • 8.6.2. Brazil
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Competitive Scenario
    • 8.6.2.3. Regulatory Framework
    • 8.6.2.4. Brazil RNA extraction and purification market, 2021 - 2033 (USD Million)
  • 8.6.3. Argentina
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Competitive Scenario
    • 8.6.3.3. Regulatory Framework
    • 8.6.3.4. Argentina RNA extraction and purification market, 2021 - 2033 (USD Million)
• 8.7. MEA
  • 8.7.1. MEA RNA extraction and purification market, 2021 - 2033 (USD Million)
  • 8.7.2. South Africa
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Competitive Scenario
    • 8.7.2.3. Regulatory Framework
    • 8.7.2.4. South Africa RNA extraction and purification market, 2021 - 2033 (USD Million)
  • 8.7.3. Saudi Arabia
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Competitive Scenario
    • 8.7.3.3. Regulatory Framework
    • 8.7.3.4. Saudi Arabia RNA extraction and purification market, 2021 - 2033 (USD Million)
  • 8.7.4. UAE
    • 8.7.4.1. Key Country Dynamics
    • 8.7.4.2. Competitive Scenario
    • 8.7.4.3. Regulatory Framework
    • 8.7.4.4. UAE RNA extraction and purification market, 2021 - 2033 (USD Million)
  • 8.7.5. Kuwait
    • 8.7.5.1. Key Country Dynamics
    • 8.7.5.2. Competitive Scenario
    • 8.7.5.3. Regulatory Framework
    • 8.7.5.4. Kuwait RNA extraction and purification market, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Company Categorization
• 9.2. Strategy Mapping
• 9.3. Company Market Position Analysis, 2025
• 9.4. Company Profiles/Listing
  • 9.4.1. Agilent Technologies, Inc.
    • 9.4.1.1. Overview
    • 9.4.1.2. Financial Performance
    • 9.4.1.3. Product Benchmarking
    • 9.4.1.4. Strategic Initiatives
  • 9.4.2. Bio-Rad Laboratories, Inc.
    • 9.4.2.1. Overview
    • 9.4.2.2. Financial Performance
    • 9.4.2.3. Product Benchmarking
    • 9.4.2.4. Strategic Initiatives
  • 9.4.3. Danaher Corporation
    • 9.4.3.1. Overview
    • 9.4.3.2. Financial Performance
    • 9.4.3.3. Product Benchmarking
    • 9.4.3.4. Strategic Initiatives
  • 9.4.4. F. Hoffmann-La Roche Ltd.
    • 9.4.4.1. Overview
    • 9.4.4.2. Financial Performance
    • 9.4.4.3. Product Benchmarking
    • 9.4.4.4. Strategic Initiatives
  • 9.4.5. Geno Technology, Inc.
    • 9.4.5.1. Overview
    • 9.4.5.2. Financial Performance
    • 9.4.5.3. Product Benchmarking
    • 9.4.5.4. Strategic Initiatives
  • 9.4.6. HiMedia Laboratories Private Limited
    • 9.4.6.1. Overview
    • 9.4.6.2. Financial Performance
    • 9.4.6.3. Product Benchmarking
    • 9.4.6.4. Strategic Initiatives
  • 9.4.7. Illumina, Inc.
    • 9.4.7.1. Overview
    • 9.4.7.2. Financial Performance
    • 9.4.7.3. Product Benchmarking
    • 9.4.7.4. Strategic Initiatives
  • 9.4.8. New England Biolabs, Inc.
    • 9.4.8.1. Overview
    • 9.4.8.2. Financial Performance
    • 9.4.8.3. Product Benchmarking
    • 9.4.8.4. Strategic Initiatives
  • 9.4.9. Norgen Biotek Corp.
    • 9.4.9.1. Overview
    • 9.4.9.2. Financial Performance
    • 9.4.9.3. Product Benchmarking
    • 9.4.9.4. Strategic Initiatives
  • 9.4.10. Promega Corporation
    • 9.4.10.1. Overview
    • 9.4.10.2. Financial Performance
    • 9.4.10.3. Product Benchmarking
    • 9.4.10.4. Strategic Initiatives